Georgia D. Tomaras

29.3k total citations · 1 hit paper
190 papers, 6.4k citations indexed

About

Georgia D. Tomaras is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Georgia D. Tomaras has authored 190 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Virology, 117 papers in Immunology and 53 papers in Infectious Diseases. Recurrent topics in Georgia D. Tomaras's work include HIV Research and Treatment (160 papers), Immune Cell Function and Interaction (72 papers) and T-cell and B-cell Immunology (44 papers). Georgia D. Tomaras is often cited by papers focused on HIV Research and Treatment (160 papers), Immune Cell Function and Interaction (72 papers) and T-cell and B-cell Immunology (44 papers). Georgia D. Tomaras collaborates with scholars based in United States, United Kingdom and South Africa. Georgia D. Tomaras's co-authors include Barton F. Haynes, David C. Montefiori, Guido Ferrari, Andrew J. McMichael, Persephone Borrow, Nilu Goonetilleke, M. Anthony Moody, Hua‐Xin Liao, Kent J. Weinhold and S. Munir Alam and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Georgia D. Tomaras

177 papers receiving 6.3k citations

Hit Papers

The immune response durin... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georgia D. Tomaras United States 44 4.5k 3.7k 1.8k 1.5k 1.4k 190 6.4k
Pascal Poignard United States 37 5.1k 1.1× 3.6k 1.0× 1.9k 1.1× 1.8k 1.2× 1.1k 0.8× 69 6.7k
Guido Ferrari United States 45 3.8k 0.8× 3.3k 0.9× 1.7k 0.9× 1.3k 0.9× 1.4k 1.0× 191 5.8k
Donald N. Forthal United States 38 3.5k 0.8× 2.6k 0.7× 2.3k 1.2× 1.3k 0.9× 1.9k 1.4× 100 6.3k
Hendrik Streeck United States 42 3.4k 0.8× 4.3k 1.2× 1.9k 1.1× 1.1k 0.7× 1.2k 0.9× 116 6.8k
Ann J. Hessell United States 25 3.4k 0.7× 2.5k 0.7× 1.6k 0.9× 1.2k 0.8× 1.2k 0.9× 63 5.0k
Paul A. Goepfert United States 45 4.1k 0.9× 3.8k 1.0× 2.0k 1.1× 1.4k 0.9× 1.7k 1.2× 144 6.9k
Mark K. Louder United States 34 4.1k 0.9× 2.7k 0.7× 2.3k 1.3× 1.3k 0.8× 1.0k 0.8× 61 5.7k
Florian Klein Germany 44 3.9k 0.9× 3.1k 0.9× 2.8k 1.5× 1.9k 1.2× 1.3k 0.9× 159 7.8k
Peter L. Nara United States 42 4.4k 1.0× 2.7k 0.7× 2.2k 1.2× 1.8k 1.2× 1.4k 1.1× 99 6.5k
Gabriela Stiegler United States 36 6.0k 1.3× 3.8k 1.0× 2.3k 1.3× 2.4k 1.6× 1.4k 1.0× 47 7.8k

Countries citing papers authored by Georgia D. Tomaras

Since Specialization
Citations

This map shows the geographic impact of Georgia D. Tomaras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia D. Tomaras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia D. Tomaras more than expected).

Fields of papers citing papers by Georgia D. Tomaras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia D. Tomaras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia D. Tomaras. The network helps show where Georgia D. Tomaras may publish in the future.

Co-authorship network of co-authors of Georgia D. Tomaras

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia D. Tomaras. A scholar is included among the top collaborators of Georgia D. Tomaras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia D. Tomaras. Georgia D. Tomaras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manickam, Cordelia, et al.. (2025). Myeloid cell recruitment and activation through systemic and mucosae‐directed cytokine therapy. Immunology and Cell Biology. 103(10). 945–956.
2.
Montefiori, David C., Guido Ferrari, Dieter Mielke, LaTonya D. Williams, & Georgia D. Tomaras. (2025). Current Approaches for Assessments of Neutralizing, Binding, and Effector Functions of Antibodies on the Path to Antibody-Mediated Prevention Strategies for HIV-1. Current HIV Research. 23(6). 428–441.
3.
Horn, Gillian Q., Kathryn M. Hastie, Haoyang Li, et al.. (2023). Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants. Journal of Virology. 97(12). e0107023–e0107023.
4.
Verheul, Marije K., Katherine L. Williams, Celina Jin, et al.. (2021). Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses. Science Immunology. 6(64). eabj1181–eabj1181. 9 indexed citations
5.
Andersen‐Nissen, Erica, Andrew Fioré-Gartland, Lamar Ballweber-Fleming, et al.. (2021). Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk. PLoS Pathogens. 17(3). e1009363–e1009363. 20 indexed citations
6.
Jin, Celina, Jennifer Hill, Bronwyn M. Gunn, et al.. (2020). Vi-specific serological correlates of protection for typhoid fever. The Journal of Experimental Medicine. 218(2). 45 indexed citations
7.
Fourati, Slim, Susan Pereira Ribeiro, Aarthi Talla, et al.. (2019). Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine. Nature Communications. 10(1). 863–863. 24 indexed citations
8.
Fong, Youyi, Coleen K. Cunningham, Elizabeth J. McFarland, et al.. (2017). HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine. Journal of Virology. 92(1). 25 indexed citations
9.
Meyerhoff, Robert, Richard M. Scearce, Joy Pickeral, et al.. (2017). HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies. AIDS Research and Human Retroviruses. 33(8). 859–868. 8 indexed citations
10.
Knox, James J., Marcus Buggert, Lela Kardava, et al.. (2017). T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response. JCI Insight. 2(8). 114 indexed citations
11.
Tay, Matthew Zirui, Pinghuang Liu, LaTonya D. Williams, et al.. (2016). Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses. PLoS Pathogens. 12(8). e1005817–e1005817. 79 indexed citations
12.
Huang, Ying, Carlos A. DiazGranados, Holly Janes, et al.. (2016). Selection of HIV vaccine candidates for concurrent testing in an efficacy trial. Current Opinion in Virology. 17. 57–65. 7 indexed citations
13.
Liu, Pinghuang, LaTonya D. Williams, Xiaoying Shen, et al.. (2014). Capacity for Infectious HIV-1 Virion Capture Differs by Envelope Antibody Specificity. Journal of Virology. 88(9). 5165–5170. 28 indexed citations
14.
Kepler, Thomas B., Supriya Munshaw, Kevin Wiehe, et al.. (2014). Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation. Frontiers in Immunology. 5. 170–170. 58 indexed citations
15.
Grand, Roger Le, Stefania Dispinseri, Laurent Gosse, et al.. (2014). Microbicide-vaccine Combination Provides Significant Protection against Vaginal SHIV-162P3 Challenge in Cynomolgous Monkeys. AIDS Research and Human Retroviruses. 30(S1). A26–A26. 1 indexed citations
16.
Prentice, Heather A., Daniel E. Geraghty, Georgia D. Tomaras, et al.. (2014). Immune Correlates Identified in the RV144 Vaccine Efficacy Trial Impact HIV-1 Acquisition Only in the Presence of Certain HLA Class II Genes. AIDS Research and Human Retroviruses. 30(S1). A40–A40.
17.
Hay, Christine M., Gregory J. Wilson, Marnie Elizaga, et al.. (2014). An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults. AIDS Research and Human Retroviruses. 30(S1). A17–A17. 1 indexed citations
18.
Liu, Jinyan, Brandon F. Keele, Hui Li, et al.. (2010). Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys. Journal of Virology. 84(19). 10406–10412. 88 indexed citations
19.
Binley, James Μ., Emma T. Crooks, Michael S. Seaman, et al.. (2008). Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C. Journal of Virology. 82(23). 11651–11668. 278 indexed citations
20.
Alam, S. Munir, Richard M. Scearce, Robert Parks, et al.. (2007). Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection. Journal of Virology. 82(1). 115–125. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026